Our findings provide evidence of GSDME activation during the progression of atherosclerosis and confirm that the deficiency of GSDME exhibited significant effects on reducing atherogenesis and diminishing vascular inflammation in ApoE−/− mice. The gene discussed is APOE; the disease is atherosclerosis.